MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 15, 2007; DOI: 10.1124/mol.107.037002


0026-895X/07/7205-1301-1309$20.00
Mol Pharmacol 72:1301-1309, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.037002v1
72/5/1301    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno, L.
Right arrow Articles by Perez-Vizcaino, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreno, L.
Right arrow Articles by Perez-Vizcaino, F.

Role of Protein Kinase C{zeta} and Its Adaptor Protein p62 in Voltage-Gated Potassium Channel Modulation in Pulmonary Arteries

Laura Moreno, Giovanna Frazziano, Angel Cogolludo, Laura Cobeño, Juan Tamargo, and Francisco Perez-Vizcaino

Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain

Voltage-gated potassium (KV) channels play an essential role in regulating pulmonary artery function, and they underpin the phenomenon of hypoxic pulmonary vasoconstriction. Pulmonary hypertension is characterized by inappropriate vasoconstriction, vascular remodeling, and dysfunctional KV channels. In the current study, we aimed to elucidate the role of PKC{zeta} and its adaptor protein p62 in the modulation of KV channels. We report that the thromboxane A2 analog 9,11-dideoxy-11{alpha},9{alpha}-epoxymethano-prostaglandin F2{alpha} methyl acetate (U46619 [GenBank] ) inhibited KV currents in isolated mice pulmonary artery myocytes and the KV current carried by human cloned KV1.5 channels expressed in Ltk cells. Using protein kinase C (PKC){zeta}–/– and p62–/– mice, we demonstrate that these two proteins are involved in the KV channel inhibition. PKC{zeta} coimmunoprecipitated with KV1.5, and this interaction was markedly reduced in p62–/– mice. Pulmonary arteries from PKC{zeta}–/– mice also showed a diminished [Ca2+]i and contractile response, whereas genetic inactivation of p62–/– resulted in an absent [Ca2+]i response, but it preserved contractile response to U46619. [GenBank] These data demonstrate that PKC{zeta} and its adaptor protein p62 play a key role in the modulation of KV channel function in pulmonary arteries. These observations identify PKC{zeta} and/or p62 as potential therapeutic targets for the treatment of pulmonary hypertension.


Received April 12, 2007; accepted August 15, 2007

Address correspondence to: Dr. Francisco Perez-Vizcaino, Department of Pharmacology, School of Medicine, Universidad Complutense, 28040 Madrid, Spain. E-mail: fperez{at}med.ucm.es




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. Cogolludo, L. Moreno, G. Frazziano, J. Moral-Sanz, C. Menendez, J. Castaneda, C. Gonzalez, E. Villamor, and F. Perez-Vizcaino
Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction
Cardiovasc Res, May 1, 2009; 82(2): 296 - 302.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics